NASDAQ · Drug Manufacturers - Specialty & Generic

PAHC (PAHC) Stock

$36.01 -1.59% NASDAQ: PAHC Healthcare

Valuation

MetricValue
Price$36.01
Market Cap$1.46B
P/E Ratio28.72
P/B Ratio4.84
P/S Ratio0.91
EPS (TTM)$1.19
52-Week High$60.08
52-Week Low$23.61
Dividend Yield1.42%

Financials & Margins

MetricValue
ROE16.78%
ROA3.53%
ROCE38.46%
Gross Margin8.49%
Operating Margin8.49%
Net Margin6.35%
Debt/Equity2.18
Current Ratio2.77

Annual Financials (USD)

Metric20212022202320242025
Revenue$833.0M$942.0M$978.0M$1.0B$1.3B
Operating Profit$75.0M$79.0M$72.0M$53.0M$110.0M
Net Profit$54.0M$49.0M$33.0M$2.0M$48.0M
EPS$1.34$1.21$0.81$0.06$1.19
Op Margin9.0%8.4%7.3%5.2%8.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$841.0M$932.0M$971.0M$982.0M$1.4B
Total Liabilities$603.0M$669.0M$689.0M$726.0M$1.1B
Cash$50.0M$74.0M$41.0M$71.0M$68.0M
Borrowings$427.0M$470.0M$510.0M$525.0M$762.0M

Latest News

Is Phibro Animal Health (PAHC) Stock Undervalued Right Now? Zacks · Jul 22, 2026 PAHC: Raising target price to $32.00 Argus Research · Jul 22, 2026 Is This the Right Time to Hold MYGN Stock in Your Portfolio? Zacks · Jul 15, 2026 3 of Wall Street’s Favorite Stocks with Warning Signs StockStory · Jul 13, 2026 PAHC or LZAGY: Which Is the Better Value Stock Right Now? Zacks · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$48.0M$32.0M$13.0M$88.0M$80.0M
Investing Cash Flow$-48.0M$-60.0M$-126.0M$-89.0M$-327.0M
Financing Cash Flow$-3.0M$-5.0M$4.0M$0$-9.0M
Net Cash Flow$14.0M$24.0M$-33.0M$29.0M$-3.0M
Free Cash Flow$19.0M$-5.0M$-38.0M$46.0M$42.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA13.33
FCF Yield0.93%
Quick Ratio1.26
Interest Coverage3.33
Return 1Y15.70%
Return 3Y141.94%
Return 5Y50.10%

Ownership

Insiders Held0.85%
Institutions Held100.61%
Institutions Float Held101.47%
Institutional HolderSharesReport Date
Blackrock Inc.3,253,8482026-03-31
FMR, LLC2,173,1262026-03-31
State Street Corporation950,0332026-03-31
Vanguard Capital Management LLC891,2832026-03-31
Acadian Asset Management. LLC617,0722026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALVOAlvotech $3.16 +3.10% -10.76 $1.07B 0.00%
ANIP $82.63 +3.44% 24.92 $1.88B 0.00%
AUPH $15.00 -1.19% 7.46 $1.93B 0.00%
AVDLAvadel Pharmaceuticals plc $21.64 +0.00% 431.08 $2.12B 0.00%
BGMBGM Group Ltd. $0.30 -1.10% -1.82 $59.61M 0.00%

About PAHC

PAHC is led by CEO Jack Clifford Bendheim, employs 1,940 people, headquartered in US, publicly traded since 2014.

PAHC stock trades at $36.01 with a market capitalization of $1.46B. The stock is valued at a price-to-earnings (P/E) ratio of 28.72, price-to-book of 4.84, price-to-sales of 0.91. Over the past 52 weeks the stock has ranged between $23.61 and $60.08, and currently trades 40.1% below its 52-week high. It pays a dividend yielding 1.42%.

On profitability, PAHC generates a return on equity (ROE) of 16.78%, above the typical market average, return on capital employed of 38.46%, an operating margin of 8.49%, a net profit margin of 6.35%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides